These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 35663525)

  • 1. Quality assessment of a serum and xenofree medium for the expansion of human GMP-grade mesenchymal stromal cells.
    Aussel C; Busson E; Vantomme H; Peltzer J; Martinaud C
    PeerJ; 2022; 10():e13391. PubMed ID: 35663525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation and prolonged expansion of oral mesenchymal stem cells under clinical-grade, GMP-compliant conditions differentially affects "stemness" properties.
    Bakopoulou A; Apatzidou D; Aggelidou E; Gousopoulou E; Leyhausen G; Volk J; Kritis A; Koidis P; Geurtsen W
    Stem Cell Res Ther; 2017 Nov; 8(1):247. PubMed ID: 29096714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of culture media on large-scale expansion and characteristic of adipose tissue-derived mesenchymal stromal cells.
    Czapla J; Matuszczak S; Kulik K; Wiśniewska E; Pilny E; Jarosz-Biej M; Smolarczyk R; Sirek T; Zembala MO; Zembala M; Szala S; Cichoń T
    Stem Cell Res Ther; 2019 Aug; 10(1):235. PubMed ID: 31383013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved biological performance of human cartilage-derived progenitors in platelet lysate xenofree media in comparison to fetal bovine serum media.
    Mantripragada VP; Muschler GF
    Curr Res Transl Med; 2022 Sep; 70(4):103353. PubMed ID: 35940083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toward a clinical-grade expansion of mesenchymal stem cells from human sources: a microcarrier-based culture system under xeno-free conditions.
    Santos Fd; Andrade PZ; Abecasis MM; Gimble JM; Chase LG; Campbell AM; Boucher S; Vemuri MC; Silva CL; Cabral JM
    Tissue Eng Part C Methods; 2011 Dec; 17(12):1201-10. PubMed ID: 21895491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accelerated and safe expansion of human mesenchymal stromal cells in animal serum-free medium for transplantation and regenerative medicine.
    Lange C; Cakiroglu F; Spiess AN; Cappallo-Obermann H; Dierlamm J; Zander AR
    J Cell Physiol; 2007 Oct; 213(1):18-26. PubMed ID: 17458897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum-free human MSC medium supports consistency in human but not in equine adipose-derived multipotent mesenchymal stromal cell culture.
    Schubert S; Brehm W; Hillmann A; Burk J
    Cytometry A; 2018 Jan; 93(1):60-72. PubMed ID: 28926198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Media matters: culture medium-dependent hypervariable phenotype of mesenchymal stromal cells.
    Fitzgerald JC; Shaw G; Murphy JM; Barry F
    Stem Cell Res Ther; 2023 Dec; 14(1):363. PubMed ID: 38087388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pancreas-derived mesenchymal stromal cells share immune response-modulating and angiogenic potential with bone marrow mesenchymal stromal cells and can be grown to therapeutic scale under Good Manufacturing Practice conditions.
    Thirlwell KL; Colligan D; Mountford JC; Samuel K; Bailey L; Cuesta-Gomez N; Hewit KD; Kelly CJ; West CC; McGowan NWA; Casey JJ; Graham GJ; Turner ML; Forbes S; Campbell JDM
    Cytotherapy; 2020 Dec; 22(12):762-771. PubMed ID: 32828673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human platelet lysate in mesenchymal stromal cell expansion according to a GMP grade protocol: a cell factory experience.
    Becherucci V; Piccini L; Casamassima S; Bisin S; Gori V; Gentile F; Ceccantini R; De Rienzo E; Bindi B; Pavan P; Cunial V; Allegro E; Ermini S; Brugnolo F; Astori G; Bambi F
    Stem Cell Res Ther; 2018 May; 9(1):124. PubMed ID: 29720245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A critical appraisal of humanized alternatives to fetal bovine serum for clinical applications of umbilical cord derived mesenchymal stromal cells.
    Rallapalli S; Guhathakurta S; Bishi DK; Subbarayan R; Mathapati S; Korrapati PS
    Biotechnol Lett; 2021 Oct; 43(10):2067-2083. PubMed ID: 34499291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimization and scale-up culture of human endometrial multipotent mesenchymal stromal cells: potential for clinical application.
    Rajaraman G; White J; Tan KS; Ulrich D; Rosamilia A; Werkmeister J; Gargett CE
    Tissue Eng Part C Methods; 2013 Jan; 19(1):80-92. PubMed ID: 22738377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Local manufacturing processes contribute to variability in human mesenchymal stromal cell expansion while growth media supplements contribute to variability in gene expression and cell function: a Biomedical Excellence for Safer Transfusion (BEST) collaborative study.
    Shaz BH; Schäfer R; Fontaine MJ; Norris PJ; McKenna DH; Jin P; Reems JA; Stroncek D; Tanashi M; Marks D; Geng H; Pati S;
    Cytotherapy; 2024 Jun; 26(6):531-539. PubMed ID: 38043052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of GMP-compliant culture media for in vitro expansion of human bone marrow mesenchymal stromal cells.
    Wuchter P; Vetter M; Saffrich R; Diehlmann A; Bieback K; Ho AD; Horn P
    Exp Hematol; 2016 Jun; 44(6):508-18. PubMed ID: 26911671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Xeno-Free Cultivation of Mesenchymal Stem Cells From the Corneal Stroma.
    Matthyssen S; Ní Dhubhghaill S; Van Gerwen V; Zakaria N
    Invest Ophthalmol Vis Sci; 2017 May; 58(5):2659-2665. PubMed ID: 28524929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of the mesenchymal stromal cell source on the hematopoietic supportive capacity of umbilical cord blood-derived CD34
    Bucar S; Branco ADM; Mata MF; Milhano JC; Caramalho Í; Cabral JMS; Fernandes-Platzgummer A; da Silva CL
    Stem Cell Res Ther; 2021 Jul; 12(1):399. PubMed ID: 34256848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcium chloride declotted human platelet lysate promotes the expansion of mesenchymal stromal cells and allows manufacturing of immunomodulatory active extracellular vesicle products.
    Mouloud Y; Staubach S; Stambouli O; Mokhtari S; Kutzner TJ; Zwanziger D; Hemeda H; Giebel B
    Cytotherapy; 2024 Sep; 26(9):988-998. PubMed ID: 38819364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of different culture conditions for human mesenchymal stromal cells for clinical stem cell therapy.
    Haack-Sorensen M; Friis T; Bindslev L; Mortensen S; Johnsen HE; Kastrup J
    Scand J Clin Lab Invest; 2008; 68(3):192-203. PubMed ID: 17852829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A xenogeneic-free bioreactor system for the clinical-scale expansion of human mesenchymal stem/stromal cells.
    Dos Santos F; Campbell A; Fernandes-Platzgummer A; Andrade PZ; Gimble JM; Wen Y; Boucher S; Vemuri MC; da Silva CL; Cabral JM
    Biotechnol Bioeng; 2014 Jun; 111(6):1116-27. PubMed ID: 24420557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Scalable Production of Equine Platelet Lysate for Multipotent Mesenchymal Stromal Cell Culture.
    Hagen A; Lehmann H; Aurich S; Bauer N; Melzer M; Moellerberndt J; Patané V; Schnabel CL; Burk J
    Front Bioeng Biotechnol; 2020; 8():613621. PubMed ID: 33553119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.